Leflunomide as a therapeutic alternative to methotrexate as a glucocorticoid-sparing agent in polymyalgia rheumatica

Rheumatol Adv Pract. 2024 Mar 28;8(2):rkae047. doi: 10.1093/rap/rkae047. eCollection 2024.

Authors

Miguel A González-Gay^{1

2}, Elena Heras-Recuero¹, Teresa Blázquez-Sánchez¹, Santos Castañeda³, Raquel Largo¹

Affiliations

¹ Division of Rheumatology, IIS-Fundación Jiménez Díaz, Madrid, Spain.
² Medicine and Psychiatry Department, Universidad of Cantabria, Santander, Spain.
³ Division of Rheumatology, Hospital Universitario de La Princesa, IIS-Princesa, Madrid, Spain.

No abstract available

Publication types

Editorial